Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion type Assertion NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_head.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion description "[We assessed TIL expression of interleukin-2 (IL-2), IL-4, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), granulocyte-macrophage colony stimulating factor (GM-CSF), IL-10, and transforming growth factor-beta (TGF-beta), and tumor cell expression of IL-10 and TGF-beta in situ in 49 primary colon carcinomas and 20 metastases using immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_provenance.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion evidence source_evidence_literature NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_provenance.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion SIO_000772 8826937 NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_provenance.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion wasDerivedFrom befree-20150227 NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_provenance.
- NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_assertion wasGeneratedBy ECO_0000203 NP503096.RAexdS2CC5elezmQ4svMZwcSD8SEunOjcZfZKat0GTh-I130_provenance.